ArticleCancer immunology, immunotherapy : CII2024

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Huan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.